Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HXX1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 168 | 172 | PF00656 | 0.616 |
CLV_C14_Caspase3-7 | 24 | 28 | PF00656 | 0.702 |
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.530 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.575 |
CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.608 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.561 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.441 |
CLV_PCSK_FUR_1 | 100 | 104 | PF00082 | 0.624 |
CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.542 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.307 |
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.563 |
CLV_PCSK_PC1ET2_1 | 141 | 143 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.565 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.680 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 84 | 88 | PF00082 | 0.390 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.724 |
DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.579 |
DOC_USP7_UBL2_3 | 37 | 41 | PF12436 | 0.632 |
DOC_USP7_UBL2_3 | 71 | 75 | PF12436 | 0.489 |
LIG_LIR_Gen_1 | 163 | 172 | PF02991 | 0.585 |
LIG_LIR_Nem_3 | 163 | 169 | PF02991 | 0.582 |
LIG_SH2_STAT3 | 117 | 120 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.437 |
MOD_CK1_1 | 131 | 137 | PF00069 | 0.470 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.515 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.645 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.393 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.624 |
MOD_PKA_1 | 22 | 28 | PF00069 | 0.652 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.333 |
MOD_Plk_2-3 | 132 | 138 | PF00069 | 0.438 |
MOD_SUMO_for_1 | 107 | 110 | PF00179 | 0.417 |
MOD_SUMO_for_1 | 121 | 124 | PF00179 | 0.478 |
MOD_SUMO_rev_2 | 134 | 143 | PF00179 | 0.459 |
TRG_DiLeu_BaEn_1 | 139 | 144 | PF01217 | 0.517 |
TRG_DiLeu_LyEn_5 | 139 | 144 | PF01217 | 0.460 |
TRG_ER_diArg_1 | 100 | 103 | PF00400 | 0.511 |
TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.575 |
TRG_ER_diArg_1 | 48 | 51 | PF00400 | 0.681 |
TRG_NLS_Bipartite_1 | 4 | 20 | PF00514 | 0.556 |
TRG_NLS_Bipartite_1 | 57 | 74 | PF00514 | 0.443 |
TRG_NLS_MonoCore_2 | 13 | 18 | PF00514 | 0.575 |
TRG_NLS_MonoExtC_3 | 14 | 19 | PF00514 | 0.559 |
TRG_NLS_MonoExtN_4 | 11 | 18 | PF00514 | 0.575 |
TRG_Pf-PMV_PEXEL_1 | 119 | 123 | PF00026 | 0.456 |
TRG_Pf-PMV_PEXEL_1 | 142 | 146 | PF00026 | 0.554 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I9L1 | Leptomonas seymouri | 69% | 98% |
A0A0S4JFM3 | Bodo saltans | 41% | 100% |
A0A1X0P6Y6 | Trypanosomatidae | 45% | 100% |
A0A3S7WUY3 | Leishmania donovani | 100% | 100% |
A4H9K6 | Leishmania braziliensis | 85% | 100% |
C9ZZT1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9ARN5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QDU4 | Leishmania major | 93% | 99% |
V5B6M9 | Trypanosoma cruzi | 44% | 100% |